Company Filing History:

9 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

3 out of 2,076

Janssen Pharmaceutica Nv

patents

1 out of 13

Johnson & Johnson Pharmaceutical Research & Development, LLC

patents

4. 2 out of 832,680

Other

patents

Years Active: 2000-2008

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7317025 - Non-peptidic NPY Y2 receptor inhibitors (2008-01-08),

2. 7199117 - Phenyl-substituted imidazopyridines (2007-04-03),

3. 7087757 - Phenyl-substituted imidazopyridines (2006-08-08),

4. 7087622 - Pyridone compounds as inhibitors of bacterial type III protein secreation systems (2006-08-08),

5. 7041828 - Phenyl-substituted imidazopyridines (2006-05-09),

6. 7041827 - Phenyl-substituted imidazopyridines (2006-05-09),

7. 6951882 - Substituted 4-phenyl-[1,3]-dioxanes (2005-10-04),

8. 6908929 - Phenyl-substituted imidazopyridines (2005-06-21),

9. 6890921 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia (2005-05-10),

10. 6841682 - Heterocycles useful in the treatment of benign prostatic hyperplasia (2005-01-11),

11. 6593474 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia (2003-07-15),

12. 6489337 - Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo[1,2-a] pyridines (2002-12-03),

13. 6436939 - Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists (2002-08-20),

14. 6384035 - Heterocycles useful in the treatment of benign prostatic hyperplasia (2002-05-07),

15. 6071915 - Arylsubstituted piperazines useful in the treatment of benign prostatic (2000-06-06),

Title: The Innovative Contributions of Xiaobing Li

Introduction

Xiaobing Li is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, holding a total of 15 patents. His work focuses on developing novel compounds that address various medical conditions.

Latest Patents

Among his latest patents is the invention of non-peptidic NPY Y2 receptor inhibitors. This invention provides novel non-peptidic NPY Y2 receptor inhibitors that are useful in treating or preventing anxiolytic disorders, depression, and neurological disorders. These compounds are also beneficial in modulating endocrine functions, particularly those controlled by the pituitary and hypothalamic glands, making them useful in treating conditions related to ovulation and infertility. Another notable patent involves phenyl-substituted imidazopyridines, which features pharmaceutically-active imidazopyridines and derivatives that are substituted with phenyl, along with methods of making and using them.

Career Highlights

Xiaobing Li has worked with reputable companies such as Ortho-McNeil Pharmaceutical Corp. and Janssen Pharmaceutica NV. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Throughout his career, Xiaobing Li has collaborated with notable colleagues, including Nicholas I Carruthers and William V Murray. These collaborations have further enhanced his research and development efforts.

Conclusion

Xiaobing Li's innovative work in pharmaceuticals has led to significant advancements in the treatment of various medical conditions. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.